Tolvaptan and Number Needed to Harm in Autosomal Dominant Polycystic Kidney Disease

Kidney Med. 2024 Feb 20;6(4):100802. doi: 10.1016/j.xkme.2024.100802. eCollection 2024 Apr.

Authors

Keith A Betts¹, Sasikiran Nunna², Retesh Kumar², Xiaoyu Nie¹, Ancilla W Fernandes²

Affiliations

¹ Analysis Group, Inc, Los Angeles, CA.
² Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ.

No abstract available